Literature DB >> 27034800

Widespread osteoblastic metastases and marked elevation of CA19-9 as a presentation of signet ring cell gastric carcinoma.

Yuval Link1, Asaf Romano1, Jacob Bejar1, Elad Schiff1, Yaniv Dotan1.   

Abstract

Widespread osteoblastic metastases, as well as marked elevations of CA19-9 and carcino-embryonic antigen (CEA), are the initial manifestations of gastric signet ring cell carcinoma. CT Imaging revealed diffuse sclerotic metastases in the axial skeleton. It was only following gastric biopsy that the primary site of metastatic bone tumor was identified. Recent studies suggest that early diagnosis of cancer origin, including tumor molecular profiling, may dictate specific therapy, improve prognosis and increase patient survival rates.

Entities:  

Keywords:  CA19-9; Gastric signet ring cell carcinoma; carcino-embryonic antigen (CEA); osteoblastic metastases

Year:  2016        PMID: 27034800      PMCID: PMC4783745          DOI: 10.3978/j.issn.2078-6891.2015.086

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  25 in total

Review 1.  Metastasis to bone: causes, consequences and therapeutic opportunities.

Authors:  Gregory R Mundy
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

Review 2.  Microarray and histopathological analysis of tumours: the future and the past?

Authors:  S R Lakhani; A Ashworth
Journal:  Nat Rev Cancer       Date:  2001-11       Impact factor: 60.716

Review 3.  Basic mechanisms responsible for osteolytic and osteoblastic bone metastases.

Authors:  Theresa A Guise; Khalid S Mohammad; Gregory Clines; Elizabeth G Stebbins; Darren H Wong; Linda S Higgins; Robert Vessella; Eva Corey; Susan Padalecki; Larry Suva; John M Chirgwin
Journal:  Clin Cancer Res       Date:  2006-10-15       Impact factor: 12.531

4.  Multiclass cancer diagnosis using tumor gene expression signatures.

Authors:  S Ramaswamy; P Tamayo; R Rifkin; S Mukherjee; C H Yeang; M Angelo; C Ladd; M Reich; E Latulippe; J P Mesirov; T Poggio; W Gerald; M Loda; E S Lander; T R Golub
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-11       Impact factor: 11.205

5.  Elevated tumour marker CA19-9: clinical interpretation and influence of obstructive jaundice.

Authors:  D V Mann; R Edwards; S Ho; W Y Lau; G Glazer
Journal:  Eur J Surg Oncol       Date:  2000-08       Impact factor: 4.424

6.  MicroRNA expression profiles classify human cancers.

Authors:  Jun Lu; Gad Getz; Eric A Miska; Ezequiel Alvarez-Saavedra; Justin Lamb; David Peck; Alejandro Sweet-Cordero; Benjamin L Ebert; Raymond H Mak; Adolfo A Ferrando; James R Downing; Tyler Jacks; H Robert Horvitz; Todd R Golub
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

7.  The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.

Authors:  X G Ni; X F Bai; Y L Mao; Y F Shao; J X Wu; Y Shan; C F Wang; J Wang; Y T Tian; Q Liu; D K Xu; P Zhao
Journal:  Eur J Surg Oncol       Date:  2005-03       Impact factor: 4.424

8.  CA19-9 serum levels in obstructive jaundice: clinical value in benign and malignant conditions.

Authors:  Daniele Marrelli; Stefano Caruso; Corrado Pedrazzani; Alessandro Neri; Eduardo Fernandes; Mario Marini; Enrico Pinto; Franco Roviello
Journal:  Am J Surg       Date:  2009-04-17       Impact factor: 2.565

9.  A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer.

Authors:  P M Quilty; D Kirk; J J Bolger; D P Dearnaley; V J Lewington; M D Mason; N S Reed; J M Russell; J Yardley
Journal:  Radiother Oncol       Date:  1994-04       Impact factor: 6.280

10.  The PLACORHEN study: a double-blind, placebo-controlled, randomized radionuclide study with (186)Re-etidronate in hormone-resistant prostate cancer patients with painful bone metastases. Placebo Controlled Rhenium Study.

Authors:  Shiuw H Han; John M H de Klerk; Suzy Tan; Alfred D van het Schip; Bert H Derksen; Aalt van Dijk; Cas L J J Kruitwagen; Geert H Blijham; Peter P van Rijk; Bernard A Zonnenberg
Journal:  J Nucl Med       Date:  2002-09       Impact factor: 10.057

View more
  1 in total

1.  Prostate carcinomas mimicking a digestive malignancy.

Authors:  Sorin Dema; Alis Liliana Carmen Dema; Sorina Tăban; Bianca Roxana Natarâş; Livius Cosmin Daminescu; Ciprian Constantin Duţă; Alin Adrian Cumpănaş; Tiberiu Răzvan Bardan
Journal:  Rom J Morphol Embryol       Date:  2020 Jul-Sep       Impact factor: 1.033

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.